Form 4 holding
President & Head of Research and Development
ALPINE IMMUNE SCIENCES, INC.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 20 May 2024
- Price
- $6.33
- Ownership
- Direct
Stanford L. Peng - President & Head of Research and Development at ALPINE IMMUNE SCIENCES, INC.
Issuer-level insider activity
- Role
- President & Head of Research and Development
- Issuer symbol
- ALPN
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
No buys or sells have been reported by Stanford L. Peng since 02 Jun 2025
Reported holdings for Stanford L. Peng in ALPINE IMMUNE SCIENCES, INC.
Form 4 holding
President & Head of Research and Development
ALPINE IMMUNE SCIENCES, INC.
- Security class
- Stock Option (Right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 20 May 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Stanford L. Peng in ALPINE IMMUNE SCIENCES, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.